Evox Therapeutics Completes Acquisition of Exosome AAV Technology and Intellectual Property
Oxford-based biotech Evox therapeutics, a leader in harnessing and engineering the natural delivery capabilities of extracellular vesicles (EVs), known as exosomes, has purchased Codiak Biosciences’ engEx-AAV™ technology platform. Click to read more...
Source: labmate-online.com